Health Forever
- Genetic risk profiling
- Immune system mapping
- Biomarker discovery
- Genomic risk models
- Immune response forecasting
- Disease susceptibility algorithms
- Gene editing therapies
- Vaccines for autoimmunity
- Immunomodulatory therapies
- Early mutation detection
- Immune surveillance tests
- Liquid biopsy diagnostics
- Targeted immunotherapies
- Personalized vaccines
- Cell-based treatments
- Regenerative medicine
- Stem cell therapies
- Immune system reboot strategies
Medical System Development Life Cycle (meSDLC)
- Diagnostics and risk assessment
- Define clinical/medical problem:
- Identify target users (patients, clinicians, or labs)
- Determine intended medical purpose
- Establish regulatory classification
- Define scope, risks, and constraints.
- Develop system architecture
- Create detailed design specifications
- Model workflows and data flow
- Apply safety-by-design principles
- Plan cybersecurity controls
- Code development
- Unit testing
- Integration testing
- Static & dynamic analysis
- Requirements-to-test traceability
- System-level validation testing
- Clinical/usability validation
- Final risk-benefit analysis
- Regulatory documentation submission
- Product release to market
- Monitor real-world performance
- Adverse event reporting
- Complaint handling
- Regulatory documentation submission
- Product release to market
Research
Team
Bill Ross→
COO, Founder
bill.ross@rpmr.se
Charlotte Nilsson →
Contact
Email: info@rpmr.se
Address:
Contact: sales@rpmr.se
Media relations
press@rpmr.se